Minera IRL raises funds for Ollachea project in Peru
Gold mining company Minera IRL on Monday announced plans to raise 32m Canadian dollars to be used mainly to fund development costs for its Ollachea project in Peru.
Gold mining company Minera IRL on Monday announced plans to raise 32m Canadian dollars to be used mainly to fund development costs for its Ollachea project in Peru.
The Latin American group said it intended to file a prospective supplement in Canada - other than Quebec - and the UK, US and parts of South America on a private placement basis.
The offering will be conducted on a marketed basis through a syndicate of investment dealers led by RBC Capital Markets as sole global bookrunner. It also includes Jennings Capital, Fraser Mackenzie and Desjardins Securities.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
For the Ollachea project, Minera budgeted C$4.2m for general and administration costs, permitting, community, archaeology and land acquisition, C$6.9m for detailed engineering and to advance the tunnel to 1,200 metres, and C$5.5m to take the tunnel to 1,560m for a second payment.
The remainder of funds will be used for the Don Nicolas project in Argentina, Patagonia exploration and for working capital.
The project is currently in the permitting stage following a definitive feasibility study in 2012.
Shares fell 12.38% to 46.00p at 14:36 Monday.
RD
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published
-
Will the Autumn Budget impact investment markets?
Keir Starmer has warned the Autumn Budget will be “painful”. Will it impact investment markets and should you tweak your portfolio before 30 October?
By Katie Williams Published